Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism.
about
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemIncretin action on bone: An added benefit?Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis.Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.
P2860
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Beyond glycemic control in dia ...... therapies on bone metabolism.
@en
type
label
Beyond glycemic control in dia ...... therapies on bone metabolism.
@en
prefLabel
Beyond glycemic control in dia ...... therapies on bone metabolism.
@en
P2093
P2860
P356
P1476
Beyond glycemic control in dia ...... therapies on bone metabolism.
@en
P2093
Aurora Patti
Daniela Merlotti
Elena Ceccarelli
Elisa G Guarino
Francesco Dotta
Luigi Gennari
Ranuccio Nuti
P2860
P356
10.3389/FENDO.2013.00073
P577
2013-06-18T00:00:00Z